These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8878977)

  • 1. Protein isoprenylation in Trypanosoma brucei brucei.
    Field H; Blench I; Croft S; Field MC
    Biochem Soc Trans; 1996 Aug; 24(3):433S. PubMed ID: 8878977
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of protein isoprenylation in procyclic form Trypanosoma brucei.
    Field H; Blench I; Croft S; Field MC
    Mol Biochem Parasitol; 1996 Nov; 82(1):67-80. PubMed ID: 8943151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lovastatin inhibits interferon-gamma-induced Trypanosoma brucei brucei proliferation: evidence for mevalonate pathway involvement.
    Andersson M; Löw P; Bakhiet M
    J Interferon Cytokine Res; 1996 Jun; 16(6):435-9. PubMed ID: 8807496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprenylation of proteins in the protozoan Giardia lamblia.
    Luján HD; Mowatt MR; Chen GZ; Nash TE
    Mol Biochem Parasitol; 1995 Jun; 72(1-2):121-7. PubMed ID: 8538683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous and endogenous sources of sterols in the culture-adapted procyclic trypomastigotes of Trypanosoma brucei.
    Coppens I; Courtoy PJ
    Mol Biochem Parasitol; 1995 Jul; 73(1-2):179-88. PubMed ID: 8577325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins.
    Gillespie JR; Yokoyama K; Lu K; Eastman RT; Bollinger JG; Van Voorhis WC; Gelb MH; Buckner FS
    Mol Biochem Parasitol; 2007 Jun; 153(2):115-24. PubMed ID: 17397944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined contribution of TbAT1 and TbMRPA to drug resistance in Trypanosoma brucei.
    Lüscher A; Nerima B; Mäser P
    Mol Biochem Parasitol; 2006 Dec; 150(2):364-6. PubMed ID: 16935360
    [No Abstract]   [Full Text] [Related]  

  • 8. Solution structure of SUMO from Trypanosoma brucei and its interaction with Ubc9.
    Shang Q; Xu C; Zhang J; Zhang X; Tu X
    Proteins; 2009 Jul; 76(1):266-9. PubMed ID: 19343802
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenylation of proteins in Trypanosoma brucei.
    Yokoyama K; Lin Y; Stuart KD; Gelb MH
    Mol Biochem Parasitol; 1997 Jul; 87(1):61-9. PubMed ID: 9233673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling and potential cellular target identification of K11777, a clinical cysteine protease inhibitor, in Trypanosoma brucei.
    Yang PY; Wang M; He CY; Yao SQ
    Chem Commun (Camb); 2012 Jan; 48(6):835-7. PubMed ID: 22124229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells.
    Terkeltaub R; Solan J; Barry M; Santoro D; Bokoch GM
    J Leukoc Biol; 1994 Jun; 55(6):749-55. PubMed ID: 8195701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an ENT domain from Trypanosoma brucei.
    Mi J; Yang X; Zhang J; Zhang X; Xu C; Liao S; Tu X
    Biochem Biophys Res Commun; 2018 Nov; 505(3):755-760. PubMed ID: 30293681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
    Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p.
    Watanabe Y; Kawaguchi K; Okuyama N; Sugawara Y; Obita T; Mizuguchi M; Morita M; Imanaka T
    FEBS Lett; 2016 Jan; 590(2):242-50. PubMed ID: 26762183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MORN Repeat Protein Facilitates Protein Entry into the Flagellar Pocket of Trypanosoma brucei.
    Morriswood B; Schmidt K
    Eukaryot Cell; 2015 Nov; 14(11):1081-93. PubMed ID: 26318396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy in protozoan parasites: Trypanosoma brucei as a model.
    Li FJ; He CY
    Future Microbiol; 2017 Nov; 12():1337-1340. PubMed ID: 28972412
    [No Abstract]   [Full Text] [Related]  

  • 18. An RNAi screen of the RRM-domain proteins of Trypanosoma brucei.
    Wurst M; Robles A; Po J; Luu VD; Brems S; Marentije M; Stoitsova S; Quijada L; Hoheisel J; Stewart M; Hartmann C; Clayton C
    Mol Biochem Parasitol; 2009 Jan; 163(1):61-5. PubMed ID: 18840477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition.
    Ferreira LG; Andricopulo AD
    Future Med Chem; 2013 Oct; 5(15):1753-62. PubMed ID: 24144411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.